The outcome of using intravenous immunoglobulin (IVIG) in critically ill COVID-19 patients': a retrospective, multi-centric cohort study.

Mohammadreza SalehiMahdi Barkhori MehniMohammadmehdi AkbarianSamrand Fattah GhaziNasim Khajavi RadOmid Moradi MoghaddamSaeedReza Jamali MoghaddamMasoumeh Hosseinzadeh EmamSayed Hamidreza AbtahiMaryam MoradiFereshteh Ghiasvand

Published in: European journal of medical research (2022)

Our data indicate that the use of IVIG in critically ill COVID-19 patients could not be beneficial, based on no remarkable differences in duration of hospitalization, ICU length of stay, duration of mechanical ventilation, and even mortality rate.

Keyphrases

mechanical ventilation
sars cov
acute respiratory distress syndrome
intensive care unit
respiratory failure
cardiovascular events
electronic health record
high dose
extracorporeal membrane oxygenation
risk factors
big data
type diabetes
machine learning
cardiovascular disease
low dose
artificial intelligence